Myriad Genetics | MYGN - Operating Expenses

Stock Price
5.39
Daily Change
0.05 0.94%
Monthly
-12.22%
Yearly
-58.31%
Q1 Forecast
5.45

Myriad Genetics reported $229M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 834M 20M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Mettler Toledo International USD 735.5M 17.99M Sep/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Quest Diagnostics USD 7.26B 4.94B Sep/2025
Quidel USD 2.04B 1.42B Sep/2025
Repligen USD 176.13M 279K Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Standard Biotools USD 43.02M 2.44M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Veracyte USD 108.76M 7.09M Sep/2025
Waters USD 2.33B 1.75B Sep/2025